Company announcements: Pacific HC^, IHH, StamfordTyres, SMRT

Pacific HC^ - ANNOUNCEMENT OF APPOINTMENT OF DEPUTY CHIEF EXECUTIVE OFFICER

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: PACIFIC HEALTHCARE HLDGS LTD
Stock Code/Name: P47 - Pacific HC^

ANNOUNCEMENT OF APPOINTMENT OF DEPUTY CHIEF EXECUTIVE OFFICER * Asterisks denote mandatory information Name of Announcer * PACIFIC HEALTHCARE HLDGS LTD Company Registration No. 200100544H Announcement submitted on behalf of PACIFIC HEALTHCARE HLDGS LTD Announcement is submitted with respect to * PACIFIC HEALTHCARE HLDGS LTD Announcement is submitted by * DR CHONG LAI LEONG WILLIAM Designation * EXECUTIVE DIRECTOR AND ACTING CEO Date & Time of Broadcast 08-Jan-2014 17:37:44 Announcement No. 00049   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Date of Appointment * 08/01/2014 Name of person * Wong Yee Kong (Andrew) Age * 46 Country of principal residence * Singapore The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * The Board of Directors is looking to add to the management strength of the Company. The Nominating Committee had recommended to the Board and the Board approved the appointment of Mr Wong Yee Kong (Andrew) as the Deputy Chief Executive Officer, having considered his qualifications, work experience, knowledge of, and track record in, the healthcare industry. The Board is confident that Mr. Wong will leverage his experience in the healthcare industry to help grow the Companys business. Whether appointment is executive, and if so, the area of responsibility * Executive. All responsibilities as a Deputy Chief Executive Officer. Mr. Wong will work closely with Dr William Chong, Acting Chief Executive Officer of the Company in strategic planning, daily management of corporate activities, and the implementation and oversight of business operations of the Company. Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Deputy Chief Executive Officer Working experience and occupation(s) during the past 10 years * - January 2009 to 2013 - Principal Consultant / Director, HealthPDM Pte Ltd and Strategy Maps Pte Ltd - January 2007 to January 2009 - Group Vice President (Business Development), Parkway Holdings Limited - July 2006 to January 2007 - Consultant, Khazanah Nasional Berhad - March 2005 to June 2006 - Senior Vice President (Investments), Khazanah Nasional Berhad - January 2004 to December 2004 - Head, Institutional Client Group (Global Markets), Deutsche Bank (Malaysia) Berhad Interest * in the listed issuer and its subsidiaries * Nil Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * Nil Conflict of interests (including any competing business) * Nil   >> OTHER DIRECTORSHIP # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8). Past (for the last 5 years) HealthPDM Pte Ltd Strategy Maps Pte Ltd Present HealthPDM Pte Ltd Strategy Maps Pte Ltd   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H) Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given. (a)* Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No (b)* Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No (c)* Whether there is any unsatisfied judgment against him? No (d)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No (e)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No (f)* Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No (g)* Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No (h)* Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No (i)* Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No (j)* Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- (i)* any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No (ii)* any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No (iii)* any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No (iv)* any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No (k)* Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(I) Disclosure applicable to the appointment of Director only. Any prior experience as a director of a listed company? Footnotes Attachments Total size = 0K (2048K size limit recommended)

---

IHH - MISCELLANEOUS

Announcement Type: MISCELLANEOUS
Company: IHH HEALTHCARE BERHAD
Stock Code/Name: Q0F - IHH

MISCELLANEOUS :: NOTICE OF CHANGE IN THE INTERESTS OF SUBSTANTIAL SHAREHOLDER PURSUANT TO FORM 29B OF THE MALAYSIAN COMPANIES ACT, 1965 * Asterisks denote mandatory information Name of Announcer * IHH HEALTHCARE BERHAD Company Registration No. 901914-V Announcement submitted on behalf of IHH HEALTHCARE BERHAD Announcement is submitted with respect to * IHH HEALTHCARE BERHAD Announcement is submitted by * SEOW CHING VOON Designation * COMPANY SECRETARY Date & Time of Broadcast 08-Jan-2014 17:29:08 Announcement No. 00039   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Announcement Title * NOTICE OF CHANGE IN THE INTERESTS OF SUBSTANTIAL SHAREHOLDER PURSUANT TO FORM 29B OF THE MALAYSIAN COMPANIES ACT, 1965 Description The attached announcement was made on Bursa Malaysia Securities Berhad on 8 January 2014. The initial public offering of IHH Healthcare Berhad was sponsored by CIMB Bank Berhad, Singapore Branch and DBS Bank Ltd. (the Singapore Issue Managers). The Singapore Issue Managers assume no responsibility for the contents of this announcement. Attachments IHH_Announcement_Changes_in_Substantial_Shareholder_Interest_F29B_EPF_08012014.pdf Total size =45K (2048K size limit recommended)

---

StamfordTyres - DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER

Announcement Type: DISCLOSURE OF INTEREST/CHANGES IN INTEREST
Company: STAMFORD TYRES CORPORATIONLTD
Stock Code/Name: S29 - StamfordTyres

DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER * Asterisks denote mandatory information Name of Announcer * STAMFORD TYRES CORPORATIONLTD Company Registration No. 198904416M Announcement submitted on behalf of STAMFORD TYRES CORPORATIONLTD Announcement is submitted with respect to * STAMFORD TYRES CORPORATIONLTD Announcement is submitted by * Lo Swee Oi Designation * Company Secretary Date & Time of Broadcast 08-Jan-2014 17:47:37 Announcement No. 00060   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Person(s) giving notice * Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1) Date of receipt of notice by Listed Issuer * 08/01/2014 Attachments FORM1_DW_Final.pdf Total size =225K (2048K size limit recommended)

---

StamfordTyres - DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER

Announcement Type: DISCLOSURE OF INTEREST/CHANGES IN INTEREST
Company: STAMFORD TYRES CORPORATIONLTD
Stock Code/Name: S29 - StamfordTyres

DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER * Asterisks denote mandatory information Name of Announcer * STAMFORD TYRES CORPORATIONLTD Company Registration No. 198904416M Announcement submitted on behalf of STAMFORD TYRES CORPORATIONLTD Announcement is submitted with respect to * STAMFORD TYRES CORPORATIONLTD Announcement is submitted by * Lo Swee Oi Designation * Company Secretary Date & Time of Broadcast 08-Jan-2014 17:44:35 Announcement No. 00056   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Person(s) giving notice * Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1) Date of receipt of notice by Listed Issuer * 08/01/2014 Attachments FORM1_WKW_Final.pdf Total size =225K (2048K size limit recommended)

---

SMRT - ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: SMRT CORPORATION LTD
Stock Code/Name: S53 - SMRT

ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER * Asterisks denote mandatory information Name of Announcer * SMRT CORPORATION LTD Company Registration No. 200001855H Announcement submitted on behalf of SMRT CORPORATION LTD Announcement is submitted with respect to * SMRT CORPORATION LTD Announcement is submitted by * Jacquelin Tay Gek Poh Designation * Company Secretary Date & Time of Broadcast 08-Jan-2014 17:24:47 Announcement No. 00037   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Date of Appointment * 01/03/2014 Name of person * Ong Eng Keang Age * 47 Country of principal residence * Singapore The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * See Annex A Whether appointment is executive, and if so, the area of responsibility * Executive, Finance The CFO provides overall leadership to the finance function of SMRT Group and plays a key role in developing, monitoring and evaluating overall corporate strategy with the CEO and leaders of business units with emphasis on bottom line performance, working capital and enhancing shareholder value. This position will provide useful financial insights to help make better decisions about formulating and executing strategy. Major responsibilities include corporate governance, accounting, treasury, investments and financial reporting. Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Executive Vice President and Chief Financial Officer Working experience and occupation(s) during the past 10 years * 2006 to 2014 Deputy Chief Executive Officer, Chief Financial Officer and Chief Investment Officer Hyflux Limited 1992 to 2006 Business Finance and Treasury The Dow Chemical Company Interest * in the listed issuer and its subsidiaries * NIL Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * NIL Conflict of interests (including any competing business) * NIL   >> OTHER DIRECTORSHIP # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8). Past (for the last 5 years) NIL Present NIL   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H) Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given. (a)* Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No (b)* Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No (c)* Whether there is any unsatisfied judgment against him? No (d)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No (e)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No (f)* Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No (g)* Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No (h)* Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No (i)* Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No (j)* Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- (i)* any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No (ii)* any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No (iii)* any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No (iv)* any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No (k)* Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(I) Disclosure applicable to the appointment of Director only. Any prior experience as a director of a listed company? No If no, please provide details of any training undertaken in the roles and responsibilities of a director of a listed company. N/A Footnotes Attachments AnnexA_SO.pdf Total size =10K (2048K size limit recommended)

---